Companies Like Lytix Biopharma (OB:LYTIX) Are In A Position To Invest In Growth
Jan 11
Norwegian (OSEAX) Biotech Industry Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies12
- 7D4.2%
- 3M6.5%
- 1Y-42.2%
- YTD-4.9%
In the last week, the Biotech industry is up 4.2%, with Nykode Therapeutics up 6.2%. In contrast, the industry has lost 42% in the last 12 months. In the next few years, earnings are forecast to decline by 7.2% annually.
Industry Valuation and Performance
Has the Norwegian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Feb 2023 | kr18.7b | kr813.4m | -kr1,396,596,585.00 | 24x | -13.4x | 23x |
| Mon, 02 Jan 2023 | kr19.2b | kr804.9m | -kr1,392,096,004.00 | 39.4x | -13.8x | 23.9x |
| Wed, 30 Nov 2022 | kr17.7b | kr812.8m | -kr1,396,305,402.00 | 36.3x | -12.7x | 21.8x |
| Fri, 28 Oct 2022 | kr17.5b | kr799.8m | -kr1,360,180,410.00 | 33.6x | -12.9x | 21.9x |
| Sun, 25 Sep 2022 | kr16.1b | kr813.5m | -kr1,364,650,805.00 | 35.6x | -11.8x | 19.8x |
| Tue, 23 Aug 2022 | kr21.4b | kr777.0m | -kr1,366,300,213.00 | 39.3x | -15.7x | 27.6x |
| Thu, 21 Jul 2022 | kr19.9b | kr772.6m | -kr1,381,826,129.00 | 42.5x | -14.4x | 25.7x |
| Sat, 18 Jun 2022 | kr19.5b | kr1.1b | -kr1,037,020,658.00 | 42.3x | -18.8x | 17.7x |
| Mon, 16 May 2022 | kr21.1b | kr1.1b | -kr1,012,638,822.00 | 37.4x | -20.9x | 19.4x |
| Wed, 13 Apr 2022 | kr25.0b | kr1.1b | -kr985,219,602.00 | 41.7x | -25.3x | 23.7x |
| Fri, 11 Mar 2022 | kr24.8b | kr2.7b | kr421.4m | 9x | 58.8x | 9.1x |
| Sun, 06 Feb 2022 | kr30.9b | kr2.7b | kr449.1m | 12.2x | 68.9x | 11.6x |
| Tue, 04 Jan 2022 | kr41.4b | kr2.2b | kr56.4m | 42.8x | 735.2x | 18.8x |
| Thu, 02 Dec 2021 | kr39.0b | kr2.2b | kr78.6m | 42.4x | 496.3x | 17.5x |
| Sat, 30 Oct 2021 | kr36.4b | kr2.5b | kr460.1m | 15.1x | 79.1x | 14.3x |
| Mon, 27 Sep 2021 | kr38.4b | kr2.6b | kr482.8m | 15.7x | 79.6x | 14.9x |
| Wed, 25 Aug 2021 | kr38.7b | kr2.6b | kr508.1m | 17x | 76.2x | 15x |
| Thu, 01 Jul 2021 | kr39.8b | kr2.6b | kr508.1m | 17.1x | 78.4x | 15.5x |
| Sun, 04 Apr 2021 | kr39.2b | kr2.5b | kr545.4m | 17.7x | 71.9x | 15.5x |
| Wed, 06 Jan 2021 | kr37.5b | kr2.5b | kr675.0m | 16.6x | 55.6x | 15x |
| Sat, 10 Oct 2020 | kr25.6b | kr235.2m | -kr1,189,469,577.00 | 35.4x | -21.5x | 108.7x |
| Fri, 03 Jul 2020 | kr21.9b | kr252.5m | -kr1,157,811,404.33 | 20.2x | -18.9x | 86.7x |
| Mon, 06 Apr 2020 | kr12.4b | kr268.6m | -kr1,101,468,269.79 | 23.6x | -11.3x | 46.3x |
Price to Earnings Ratio
-11.7x
Current Industry PE
- Investors are pessimistic on the Norwegian Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 38.3x is higher than the industry's current PS ratio of 23.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 52% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Norwegian Healthcare industry?
| NO Market | 1.04% | |
| Healthcare | 3.20% | |
| Biotech | 4.20% | |
| Biotech | 4.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NYKD Nykode Therapeutics | kr32.80 | 13.6% +kr1.2b | -39.5% | PS25.3x | |
| ULTI Ultimovacs | kr125.00 | 9.3% +kr364.6m | 25.9% | PB8.4x | |
| BGBIO BerGenBio | kr7.30 | 8.7% +kr51.9m | -60.3% | PS836.2x | |
| AZT ArcticZymes Technologies | kr41.90 | 0.6% +kr12.1m | -48.9% | PE64x |